429
Views
17
CrossRef citations to date
0
Altmetric
Review

The management of psychosis in movement disorder patients

, &
Pages 935-943 | Published online: 01 May 2007
 

Abstract

Psychosis may be seen with several movement disorders. As pharmacological treatments can sometimes worsen movement disorders, psychosis in these situations can be complex for clinicians to manage. This review covers the management of psychosis in three different movement disorders: Parkinson’s disease, dementia with Lewy bodies and Huntington’s disease.

Disclosure

JH Friedman is a lecture consultant for or has received research funding from: AstraZeneca, Acadia Pharmaceuticals, Ovation Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd., Guilford Pharmaceuticals Inc., Novartis, Solvay, Sepracor Inc., Cephalon. KL Chou is a lecture consultant for or has received research funding from: Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, Novartis, Boehringer Ingelheim, Solvay.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.